Plasmagen Biosciences taps into the niche Indian Biopharmaceutical market with the launch of CSL’s Haemocomplettan® P.
Mumbai, 20th June 2024: Plasmagen Biosciences Private Limited (“Plasmagen”), the Indian biopharmaceutical organization, headquartered in Bengaluru, specializing exclusively in Plasma Protein and Speciality Care Therapy, has recently announced the launch of Haemocomplettan® P […]